Evidence map›Paper›PMID 41657377›Full record

ReviewACS polymers Au2025

Synergistic Advances in Additive Manufacturing and Surface Engineering for Polymeric Biomedical Devices.

Wei Juene Chong, Antonella Sola, Yuncang Li, Paul F A Wright, Cuie Wen

Abstract readReview
In one paragraph

Review in ACS polymers Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. 2D MoSNano convergence · 2026
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei Juene ChongCentre for Additive Manufacturing, School of Engineering, RMIT University, Melbourne, Victoria 3001, Australia.ORCID https://orcid.org/0000-0002-4894-1403
Antonella SolaDepartment of Sciences and Methods for Engineering (DISMI), University of Modena and Reggio Emilia, Via Amendola 2, Reggio Emilia 42122, Italy.ORCID https://orcid.org/0000-0002-8649-9388
Yuncang LiCentre for Additive Manufacturing, School of Engineering, RMIT University, Melbourne, Victoria 3001, Australia.ORCID https://orcid.org/0000-0003-4290-4772
Paul F A WrightSchool of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria 3083, Australia.ORCID https://orcid.org/0000-0002-5722-6161
Cuie WenCentre for Additive Manufacturing, School of Engineering, RMIT University, Melbourne, Victoria 3001, Australia.ORCID https://orcid.org/0000-0001-8008-3536

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Additive manufacturing (AM) of polymeric materials is rapidly transforming the biomedical field by enabling the fabrication of patient-specific, anatomically complex structures with precise control over internal architecture. Polymers are especially attractive for AM of biomedical devices due to their cost-effectiveness, abundance, low density, and tunable mechanical and degradation properties, supporting diverse applications in soft and hard tissue engineering, microfluidics, and drug delivery. However, many medical-grade polymers interact poorly with mammalian cells and tissues due to the lack of bioactive surface functional groups, which can hinder their performance in biomedical applications that rely on cell-material interactions such as tissue regeneration. This review systematically surveys physical, chemical, and biomimetic surface modification techniques for AM-compatible medical polymers to improve biomedical applications and targeted functionalities. While much attention has been paid in the literature to surface modification in bone tissue engineering, functional coatings incorporating bioactive molecules and nanoparticles further provide antibacterial, anti-inflammatory, and pro-regenerative functions. A major emphasis of this review is the synergy between AM and surface engineering, enabling simultaneous optimization of internal architecture and surface bioactivitycapabilities fundamentally unattainable by conventional manufacturing techniques. Finally, challenges such as sterilization compatibility and long-term stability of surface modifications are discussed as key to clinical translation.

Indexed as

additive manufacturingbioactive coatingbiomimetic coatingbone tissue engineeringdrug deliverymicrofluidicspolymersurface functionalizationsurface modificationtissue regeneration

Identifiers

PMID41657377
PMCPMC12874162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.